Skip to main content
Log in

10-year follow-up of gene-modified adenoviral-based therapy in 146 non-small-cell lung cancer patients

  • Letter to the Editor
  • Published:
Cancer Gene Therapy Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y et al. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 2005; 11: 149–159.

    Article  CAS  PubMed  Google Scholar 

  2. Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol 2000; 18: 609–622.

    Article  CAS  PubMed  Google Scholar 

  3. Nemunaitis J, Cunningham C, Tong AW, Post L, Netto G, Paulson AS et al. Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients. Cancer Gene Ther 2003; 10: 341–352.

    Article  CAS  PubMed  Google Scholar 

  4. Senzer N, Mani S, Rosemurgy A, Nemunaitis J, Cunningham C, Guha C et al. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol 2004; 22: 592–601.

    Article  CAS  PubMed  Google Scholar 

  5. Nemunaitis J, Jahan T, Ross H, Sterman D, Richards D, Fox B et al. Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer. Cancer Gene Ther 2006; 13: 555–562.

    Article  CAS  PubMed  Google Scholar 

  6. Nemunaitis J, Sterman D, Jablons D, Smith JW, Fox B, Maples P et al. Granulocyte–macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer. J Natl Cancer Inst 2004; 96: 326–331.

    Article  CAS  PubMed  Google Scholar 

  7. Barlesi F, Jacot W, Astoul P, Pujol JL . Second-line treatment for advanced non-small cell lung cancer: a systematic review. Lung Cancer 2006; 51: 159–172.

    Article  PubMed  Google Scholar 

  8. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005; 353: 123–132.

    Article  CAS  PubMed  Google Scholar 

  9. Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004; 22: 1589–1597.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nemunaitis, J., Vorhies, J., Pappen, B. et al. 10-year follow-up of gene-modified adenoviral-based therapy in 146 non-small-cell lung cancer patients. Cancer Gene Ther 14, 762–763 (2007). https://doi.org/10.1038/sj.cgt.7701048

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7701048

  • Springer Nature America, Inc.

This article is cited by

Navigation